Antimalarial agent 30

CAS No. 1597425-64-3

Antimalarial agent 30( —— )

Catalog No. M37241 CAS No. 1597425-64-3

Antimalarial agent 30 has anti-Plasmodium berghei liver stage parasite activity and antimalarial activity for the study of malarial infections.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 459 In Stock
10MG 657 In Stock
25MG 1026 In Stock
50MG 1386 In Stock
100MG 1832 In Stock
200MG Get Quote In Stock
500MG 3655 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Antimalarial agent 30
  • Note
    Research use only, not for human use.
  • Brief Description
    Antimalarial agent 30 has anti-Plasmodium berghei liver stage parasite activity and antimalarial activity for the study of malarial infections.
  • Description
    Antimalarial agent 30 (compound 11) is an antimalarial agent that inhibits P. berghei liver stage parasite load with an EC50 of 5.2 μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    Parasite
  • Recptor
    Parasite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1597425-64-3
  • Formula Weight
    312.29
  • Molecular Formula
    C18H11F3N2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    FC(F)(F)C=1C=CC(=CC1)C2=NC=CC=3C=4C=CC=CC4NC23
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Neil K Viswanathan, et al. Synthesis and activity of β-carboline antimalarials targeting the Plasmodium falciparum heat shock 90 protein. Bioorg Med Chem Lett. 2023 Aug 15;92:129410.
molnova catalog
related products
  • Piperaquine tetrapho...

    Piperaquine tetraphosphate tetrahydrate is a potent anti-parasites agent.

  • DNDI-6148

    DNDI-6148 has anti-experimental cutaneous leishmaniasis activity and can be used to study visceral leishmaniasis by inhibiting Leishmania protozoa cleavage and polyadenylation-specific factor (CPSF3) endonuclease.

  • DDD107498 succinate

    DDD107498 has a potent and novel spectrum of antimalarial activity against multiple life-cycle stages of the Plasmodium parasite. It targets translation elongation factor 2 (eEF2).